Literature DB >> 19037740

A method to include the environmental hazard in drug prescribing.

Staffan Castensson1, Viktoria Eriksson, Kristina Lindborg, Björn Wettermark.   

Abstract

OBJECTIVE: Environmental classification systems for medicines have been proposed. It is important that these systems are integrated into clinical practice. Numerous studies have shown that feedback to healthcare professionals of their prescribing patterns is effective in changing behaviour. The aim of this study was to develop a method to incorporate an environmental classification for medicines in drug utilization data provided to prescribers. Drug prescribing was calculated on all pharmacy sales of medicines in ambulatory care in Stockholm, Sweden (1.9 million inhabitants) during 2006.
METHOD: Prescribing profiles were generated focusing on medicines that accounted for 90% of the volume (DU90%) of antibiotics (ATC-group J01), drugs for musculoskeletal conditions (NSAIDs, M01A), antihypertensive agents (C03, C07, C08 and C09) and antidepressants (N06A). The medicines in these 90% segments were measured as kilograms of active substance and were coded according to the classification of environmental hazard developed by Stockholm County Council and Apoteket AB. Main outcome measure Amount of pharmaceuticals dispensed (kg) and the classification of environmental hazard for the active substances accounting for the top 90% of the total amount prescribed.
RESULTS: A total of 16,800 kg of antibiotics, 23,400 kg of NSAIDs, 7,700 kg of various antihypertensive substances and 1,700 kg of antidepressants had been dispensed in the region, corresponding to 2.3, 3.3, 1.1 and 0.2 kg of drug substance per square kilometre, respectively. A total of 12, 3, 13 and 9 substances accounted for 90% of the total volume of antibiotics, NSAIDs, antihypertensives and antidepressants, respectively. The proportions of potentially high environmental hazard drugs were 0, 7, 0 and 24%, respectively.
CONCLUSION: The prescribing profiles gave an easily understandable overview for the potential environmental risk and indication for where improvement could be made. The 90% profiles were easy and inexpensive to produce using available sales data and may be a valuable tool to increase the awareness of the environmental aspects among prescribing doctors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19037740     DOI: 10.1007/s11096-008-9260-1

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  16 in total

1.  Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance.

Authors:  Dana W Kolpin; Edward T Furlong; Michael T Meyer; E Michael Thurman; Steven D Zaugg; Larry B Barber; Herbert T Buxton
Journal:  Environ Sci Technol       Date:  2002-03-15       Impact factor: 9.028

2.  Drug utilisation 90% profiles--a useful tool for quality assessment of prescribing in primary health care in Stockholm.

Authors:  Björn Wettermark; Ake Pehrsson; Dane Jinnerot; Ulf Bergman
Journal:  Pharmacoepidemiol Drug Saf       Date:  2003-09       Impact factor: 2.890

Review 3.  Significance of antibiotics in the environment.

Authors:  K Kümmerer
Journal:  J Antimicrob Chemother       Date:  2003-06-12       Impact factor: 5.790

Review 4.  Effectiveness and efficiency of guideline dissemination and implementation strategies.

Authors:  J M Grimshaw; R E Thomas; G MacLennan; C Fraser; C R Ramsay; L Vale; P Whitty; M P Eccles; L Matowe; L Shirran; M Wensing; R Dijkstra; C Donaldson
Journal:  Health Technol Assess       Date:  2004-02       Impact factor: 4.014

5.  A study of adherence to drug recommendations by providing feedback of outpatient prescribing patterns to hospital specialists.

Authors:  Björn Wettermark; Kjell Haglund; Lars L Gustafsson; Peter M Persson; Ulf Bergman
Journal:  Pharmacoepidemiol Drug Saf       Date:  2005-08       Impact factor: 2.890

Review 6.  Pharmaceuticals in the environment in Italy: causes, occurrence, effects and control.

Authors:  Ettore Zuccato; Sara Castiglioni; Roberto Fanelli; Giuseppe Reitano; Renzo Bagnati; Chiara Chiabrando; Francesco Pomati; Carlo Rossetti; Davide Calamari
Journal:  Environ Sci Pollut Res Int       Date:  2006-01       Impact factor: 4.223

Review 7.  Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe.

Authors:  Björn Wettermark; Brian Godman; Karolina Andersson; Lars L Gustafsson; Alan Haycox; Vittorio Bertele
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 8.  Glucosamine therapy for treating osteoarthritis.

Authors:  T E Towheed; L Maxwell; T P Anastassiades; B Shea; J Houpt; V Robinson; M C Hochberg; G Wells
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

9.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

Authors:  Herman Goossens; Matus Ferech; Robert Vander Stichele; Monique Elseviers
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

10.  Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis.

Authors:  D Henry; L L Lim; L A Garcia Rodriguez; S Perez Gutthann; J L Carson; M Griffin; R Savage; R Logan; Y Moride; C Hawkey; S Hill; J T Fries
Journal:  BMJ       Date:  1996-06-22
View more
  1 in total

1.  Pharmaceuticals in the environment: an educational perspective.

Authors:  Marco Eissen; Donata Backhaus
Journal:  Environ Sci Pollut Res Int       Date:  2011-05-15       Impact factor: 4.223

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.